Paul Tudor Jones Tyra Biosciences, Inc. Transaction History
Tudor Investment Corp Et Al
- $26.8 Billion
- Q3 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 26,346 shares of TYRA stock, worth $382,017. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,346Holding current value
$382,017% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TYRA
# of Institutions
98Shares Held
43.5MCall Options Held
353KPut Options Held
1.1K-
Ra Capital Management, L.P. Boston, MA10.4MShares$151 Million3.41% of portfolio
-
Boxer Capital, LLC San Diego, CA6.45MShares$93.5 Million8.05% of portfolio
-
Bvf Inc San Francisco, CA4.66MShares$67.6 Million3.48% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.41MShares$63.9 Million97.89% of portfolio
-
Nextech Invest Ag4.06MShares$58.8 Million15.55% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $609M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...